TrivarX Limited
MDBIF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $0 | $1,129 | $870 | $21 |
| % Growth | -100% | 29.8% | 3,965.7% | – |
| Cost of Goods Sold | $18 | $18 | $46 | $47 |
| Gross Profit | $18 | $1,111 | -$46 | -$37 |
| % Margin | 6,506.8% | 98.4% | -5.3% | -174% |
| R&D Expenses | $9 | $18 | $11 | $3 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $432 | $542 | $966 | $1,043 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $441 | $560 | $978 | $1,046 |
| Operating Income | -$459 | $551 | -$1,024 | -$1,093 |
| % Margin | -164,935.3% | 48.8% | -117.7% | -5,109.7% |
| Other Income/Exp. Net | -$394 | -$642 | $872 | $8 |
| Pre-Tax Income | -$852 | -$91 | -$152 | -$1,086 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$852 | -$91 | -$152 | -$1,086 |
| % Margin | -306,528.1% | -8.1% | -17.4% | -5,074.6% |
| EPS | -0.002 | -0 | -0.001 | -0.004 |
| % Growth | -700% | 60% | 85.7% | – |
| EPS Diluted | -0.002 | -0 | -0.001 | -0.004 |
| Weighted Avg Shares Out | 538,312 | 455,415 | 309,273 | 306,293 |
| Weighted Avg Shares Out Dil | 538,241 | 454,633 | 309,273 | 306,293 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $2 |
| Interest Expense | $8 | $26 | -$0 | $14 |
| Depreciation & Amortization | $20 | $32 | $46 | $47 |
| EBITDA | -$824 | -$33 | -$978 | -$1,027 |
| % Margin | -296,368% | -2.9% | -112.4% | -4,801.6% |